Endoscopic Devices - Switzerland | Statista Market Forecast

Revenue in the Endoscopic Devices market market in Switzerland is anticipated to attain US$299.70m in 2024.
This revenue is forecasted to exhibit an annual growth rate (CAGR 2024-2029) of 7.07%, which will culminate in a market volume of US$421.80m by 2029.
In a global context, the majority of revenue is projected to be produced the United States, with an expected figure of US$10.39bn in 2024.
Switzerland is witnessing a growing demand for advanced endoscopic devices, driven by its robust healthcare system and emphasis on minimally invasive surgical techniques.

Definition:
The Endoscopic Devices market, a medical technology market, includes the sale of endoscopic devices. Endoscopy involves the use of an endoscope to examine the inside of a hollow organ or body cavity. The market includes various types of endoscopes, such as gastroscopes, laparoscopes, bronchoscopes, and colonoscopes.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Olympus Corporation, Boston Scientific Corporation, and Stryker Corporation. Further information on the key players can be found in the Market Shares boxes.

Endoscopic devices
Implants such as stents

pharmaceuticals for endoscopic procedure

The Endoscopic Devices Market within the Medical Devices sector in Switzerland is experiencing moderate growth. Factors influencing this trend include technological advancements, increasing demand for minimally invasive procedures, and a growing emphasis on patient safety and recovery times.

Customer preferences: Consumers in Switzerland are showing a growing preference for advanced endoscopic procedures, largely influenced by an increasing awareness of the benefits of minimally invasive surgery. This shift is driven by an aging population seeking effective, less painful treatment options with quicker recovery times. Additionally, cultural attitudes emphasizing patient empowerment and involvement in healthcare decisions are prompting individuals to pursue innovative medical technologies. As a result, the demand for endoscopic devices is steadily rising, reflecting a broader trend towards personalized and efficient healthcare solutions.

Trends in the market: In Switzerland, the Endoscopic Devices Market is experiencing an upward trajectory, driven by advancements in technology that enhance the precision and safety of procedures. The increasing adoption of robotic-assisted endoscopy is significantly influencing surgical practices, offering improved visualization and reduced trauma. Furthermore, the integration of artificial intelligence in imaging and diagnostics is streamlining workflows and enhancing patient outcomes. These trends underscore the importance of innovation in meeting the demands of an informed patient base, prompting industry stakeholders to invest in R&D and collaborate on developing cutting-edge solutions that prioritize patient-centric care.

Local special circumstances: In Switzerland, the Endoscopic Devices Market is uniquely influenced by the nation's stringent regulatory environment and high standards for medical technology. The Swiss healthcare system emphasizes patient safety and quality, prompting manufacturers to comply with rigorous certifications that enhance device reliability. Additionally, the country's strong focus on research and innovation fosters collaboration between universities and industry players, driving advancements in minimally invasive techniques. Cultural factors, such as a high level of health literacy among the population, further propel demand for cutting-edge endoscopic solutions, ensuring that patients are well-informed and actively involved in their healthcare decisions.

Underlying macroeconomic factors: The Endoscopic Devices Market in Switzerland is shaped by macroeconomic factors including stable economic growth, robust healthcare expenditure, and a favorable investment climate. The country's strong GDP per capita and low unemployment rates contribute to a well-funded healthcare system, enabling hospitals and clinics to invest in advanced medical technologies. Additionally, Switzerland's commitment to research and development, supported by government funding and incentives, fosters innovation in endoscopic devices. Global economic trends, such as rising healthcare costs and an increasing emphasis on minimally invasive procedures, further bolster market demand, aligning with the nation's high standards for patient care and safety.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.